| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 58.629 | 65.869 | 64.452 | 99.807 | 112.518 | 96.067 | 90.015 | 102.101 | 119.747 | 127.693 |
| Total Income - EUR | 58.633 | 69.727 | 70.324 | 99.808 | 112.519 | 97.060 | 90.520 | 102.102 | 119.747 | 137.745 |
| Total Expenses - EUR | 27.430 | 32.078 | 33.521 | 40.348 | 45.659 | 44.839 | 36.553 | 43.707 | 53.218 | 89.971 |
| Gross Profit/Loss - EUR | 31.202 | 37.649 | 36.803 | 59.460 | 66.860 | 52.220 | 53.967 | 58.395 | 66.529 | 47.774 |
| Net Profit/Loss - EUR | 29.443 | 36.952 | 36.100 | 58.461 | 65.735 | 51.249 | 53.062 | 57.374 | 65.331 | 43.642 |
| Employees | 2 | 3 | 3 | 2 | 1 | 3 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Deolavimed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 8.382 | 11.285 | 11.230 | 9.606 | 8.609 | 8.956 | 8.757 | 8.785 | 29.985 | 8.709 |
| Current Assets | 145.918 | 167.676 | 172.992 | 196.988 | 165.474 | 216.827 | 265.016 | 323.280 | 234.049 | 221.936 |
| Inventories | 2.131 | 2.109 | 2.074 | 2.035 | 79 | 7 | 0 | 0 | 0 | 0 |
| Receivables | 5.238 | 4.596 | 6.391 | 14.932 | 78.521 | 208.579 | 214.488 | 282.731 | 213.448 | 185.883 |
| Cash | 138.549 | 160.971 | 164.527 | 180.021 | 86.873 | 8.242 | 50.528 | 40.548 | 20.601 | 36.053 |
| Shareholders Funds | 141.389 | 147.953 | 148.713 | 169.203 | 169.343 | 222.700 | 270.823 | 329.037 | 248.374 | 225.662 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 12.912 | 31.008 | 35.509 | 37.392 | 4.740 | 3.084 | 2.950 | 3.027 | 15.781 | 5.104 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Deolavimed S.r.l.